GoodwinDWGuzeSB. Psychiatric diagnosis. New York: Oxford University Press, 1984: 67–88.
2.
GreenblattDJShaderRI. Pharmacotherapy of anxiety with benzodiazepines and β-adrenergic blockers. In: LiptonMADiMascioAKillamKF. eds. Psychopharmacology: A generation of progress. New York: Raven Press, 1978: 1381–90.
3.
BaskinSIEsdaleA. Is chlordiazepoxide the rational choice among benzodiazepines?Pharmacotherapy1982; 2: 110–9.
4.
GreenblattDJShaderRIAbernathyDR. Current status of benzodiazepines (first of two parts). N Engl J Med1983; 309: 354–8.
5.
GreenblattDJShaderRIAbernathyDR. Current status of benzodiazepines (second of two parts). N Engl J Med1983; 309: 410–6.
6.
GrunhausLGlogerSWeisstaubE. Panic attacks: A review of treatments and pathogenesis. J Nerv Ment Dis1981; 169: 608–13.
7.
NoyesRAndersonDJClancyJ. Diazepam and propranolol in panic disorder and agoraphobia. Arch Gen Psychiatry1984; 41: 287–92.
8.
BowdenCLFisherJG. Relationship of diazepam serum level to antianxiety effects. J Clin Psychopharmacol1982; 2: 110–4.
9.
Product information. Valium. Roche Laboratories, Nutley, New Jersey, 1982.
10.
GreenblattDJ. Benzodiazepines 1980: Current update. Psychosomatics1980; 21 (suppl): 9–14.
11.
GreenblattDJShaderRI. Prazepam and lorazepam, two new benzodiazepines. N Engl J Med1978; 299: 1342–4.
12.
HollisterLE. Benzodiazepines 1980: Current update. Psvchosomatics1980; 22 (suppl): 4–8.
13.
HollisterLEMotzenbeckerFPDeganRO. Withdrawal reactions from chlordiazepoxide. Psychopharmacologia1961; 2: 63–8.
14.
WinokurARicklesKGreenblattDJ. Withdrawal reactions from long-term, low dosage administration of diazepam. Arch Gen Psychiatry1980; 37: 101–5.
15.
HoweJG. Lorazepam withdrawal seizures. Br Med J1980; 280: 1163–4.
16.
WilkinsonGR. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam, and lorazepam in man. Acta Psych Scand1978; 274 (suppl): 56–74.
17.
GreenblattDJ. Benzodiazepines 1980: Current update. Psychosomatics1980; 21 (suppl): 28.
18.
ReidenbergMMLevyMWarnerH. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther1978; 23: 371–4.
19.
ThompsonTLMoranMGNiesAS. Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med1983; 308: 134–8.
20.
ColeJOHaskellDSOrzackMH. Problems with benzodiazepines: An assessment of the available evidence. McLean Hosp J1981; 6: 46–74.
21.
KatcherBS. General care: Anxiety and insomnia. In: Koda-KimbleMAKatcherBSYoungLY, eds. Applied therapeutics for clinical pharmacists, 2nd ed. San Francisco: Applied Therapeutics, 1978: 71–85.
22.
MacKayACDundeeJW. Effect of oral benzodiazepines on memory. Br J Anaesth1980; 52: 1247–57.
23.
Teratogenicity of minor tranquilizers. FDA Drug Bull1975; 5: 14–5.
24.
HarveySC. Hypnotics and sedatives. In: GilmanAGGoodmanLSGilmanA. eds. The pharmacological basis of therapeutics, 6th ed. New York: Macmillan, 1980: 349–61.
25.
HarveySC. Hypnotics and sedatives. In: GilmanAGGoodmanLSGilmanA, eds. The pharmacological basis of therapeutics, 6th ed. New York: Macmillan, 1980: 365–7.
26.
GreenblattDJShaderRI. Meprobamate: A study of irrational drug use. Am J Psychiatry1971; 127: 1297–303.
27.
ShuckitMA. Current therapeutic options in the management of typical anxiety. J Clin Psychiatry1981; 42 (Sec 2): 15–26.
28.
KatholRGNoyesRSlymenDJ. Propranolol in chronic anxiety disorders. Arch Gen Psychiatry1980; 37: 1361–5.
